Skip to main content
. Author manuscript; available in PMC: 2015 Aug 1.
Published in final edited form as: Exp Hematol. 2014 Jun 30;42(8):609–617. doi: 10.1016/j.exphem.2014.04.008

Table 1.

Mutations in DNA modifiers in hematologic malignancies

Gene Malignancy Mutation % References
DNMT3A AML 12%–22% [22,23,92,93]
MDS 8%
MPN 7%–15%
MDS/MPN 4%

TET2 AML 12%–34 % [31,9498]
MDS 20%–25%
MPN 4%–14%
CMML 50%

IDH1/2 AML 15%–33% [35,99–104]
MDS 3.50%
T-ALL 2.5%–5%
T-cell lymphoma 5%–10%

T-ALL=T-cell acute lymphoblastic leukemia.